Mollen Immunization Clinics has developed a comprehensive school influenza immunization program called "Zap the Flu at School". This School Based Immunization Program has been designed to assist schools and communities in implementing the recommendations of both the Advisory Committees on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC) for influenza vaccination in school districts across the country.
The CDC and Mollen Immunization Clinics are working to keep you informed of the latest developments in the fight against the H1N1 (Swine Flu) virus. The most up-to-date information and frequently asked questions are addressed.
Pneumococcal disease is the cause of severe illness and even death; it kills more people in the United State each year than all other vaccine-preventable diseases combined. Everyone is susceptible to pneumococcal disease; however, some people are at greater risk from this illness. The at-risk population includes: senior -
65 and older, the very young, as well as those with health issues including alcoholism, heart or lung disease, kidney failure, diabetes, HIV infections, and certain types of cancer.
Contact Us.
Pneumococcal disease can lead to serious infections of the lungs (pneumonia), the blood (bacteremia), and the covering of the brain (meningitis). Some statistics:
People with health issues (as mentioned above) are at even greater risk to die from this disease. Drugs (e.g. penicillin) once so effective in treating these infections are now at a disadvantage as this illness becomes more drug resistant. Immunization now plays a key role in prevention of this disease.
The pneumococcal polysaccharide vaccine (PPV) protects against 23 types of pneumococcal bacteria.
Most healthy adults who receive immunization develop protection to most or all of these types within two to three weeks of receiving the shot. The at-risk population includes: the aged, children under 2 years of age,
and those with certain long-term illnesses may not respond as well, or at all.
Adults - 65 years of age or older.
Anyone - over 2 years of age - who has a long-term health issue such as:
Anyone - over 2 years of age - with a disease/condition that reduces the body’s resistance to infection, such as:
Anyone - over 2 years of age - who is taking any drug or treatment that reduces the body’s resistance to infection, such as:
Alaskan Natives and certain Native American populations.
One dose of PPV is all that is usually required, however, under some circumstances a second dose may be given. For example:
Otherwise healthy children, who often get ear infections, sinus infections, or other upper respiratory diseases, do not need to get PPV because of these conditions.
PPV may be less effective in some, especially those with lower resistance to infection, however, these people should still be immunized as they are more likely to suffer a serious illness from pneumococcal disease.
Pregnancy: The safety of PPV for pregnant women is yet to be studied; and while there is no evidence that the vaccine is harmful to either the mother or the fetus, pregnant women should consult with their doctor before being immunized. If possible, women at high risk of pneumococcal disease should be vaccinated before becoming pregnant.
While PPV is a very safe vaccine, there are instances of:
As with any medicine, there is a tiny risk that serious problems, even death, may occur after getting a vaccine. However, contracting the disease is much more likely to cause severe health issues, complications, or death. Essentially the disease presents more danger to health that the vaccine.
What should I look for?
What should I do?
Pneumonia Fact Sheet English (pdf)
Pneumonia Fact Sheet Spanish (pdf)